This email address is being protected from spambots. You need JavaScript enabled to view it.
Facebook
Twitter
SP_SOCIAL_INSTAGRAM
YouTube
Linkedin
Home
About Us
About Us
Who We Are
Our History
Global Footprint
Careers
Our Partners
Contact Us
Governance
President Emeritus
Board of Directors
Group Executive Management
South Africa Executive Management
Group Technical Leads
What We Do
What We Do
Clinical Research
Implementation Research
Health Programmes
Aurum Global
Global Projects
Aurum Institute Ghana
Fundação Aurum
Aurum USA
Expertise
Tuberculosis
HIV
Health Systems
Market Access
COVID-19
Antimicrobial resistance (AMR)
Accelerate 1
Affiliates
IMPAACT4TB
INNOVA
Youth Health Africa
GHI
Library
Resources
Publications
Annual Reports
Annual Financials
News & Updates
News
Latest News
Press Releases
Aurum in the News
Multimedia
Image Gallery
Multimedia
Aurum at 21st ICASA
Aurum was at the 21st International Conference on AIDS and Sexually Transmitted Infections (STIs) in Africa (ICASA). This year themed; The race to 2030 – Evidence. Scale Up. Accelerate, the conferen...
PhD Opportunity
The International Division and Implementation Research Division at the Aurum Institute, the TB Centre and Johns Hopkins University, CHAI, Zimbabwe and KNCV Ethiopia are offering a PhD bursary to suppo...
TB Prevention in People With HIV: How Short Can We Go?
...
Aurum at Forum on Microbial Threats workshop
Aurum Group CEO Prof Gavin Churchyard presented at the Forum on Microbial Threats workshop recently. The Forum which is part of the National Academies of Sciences, Engineering, and Medicine, brought...
Aurum Annual Report 2021
Aurum Board Chairperson Ms Phangisile Mtshali characterises 2021 as a year of adapting and building resilience. She writes in the Aurum Annual Report 2021, that the organisation had to pivot and seiz...
New study: Optimising the delivery for tuberculosis preventive treatment
The Aurum Institute is implementing a new study to assess the delivery of TB preventive treatment (TPT) in three countries, to generate critical knowledge to improve TPT uptake, implementation and ou...
Partners announce reduced price for patient-friendly tuberculosis preventive treatments
August 1, 2022: Unitaid, The Aurum Institute, the Clinton Health Access Initiative (CHAI) and MedAccess today announced two new agreements to lower the price of rifapentine (RPT)-based treatments to p...
Press Statement: Global Consortium welcomes reduced price for patient-friendly treatment to prevent tuberculosis
The Aurum Institute and its partners also announce the launch of the next phase of work to improve access to shorter TB prevention treatments for children and pregnant women Johannesburg, 3 Aug...
Aurum showcases expertise at SA TB Conference
SA TB Conference delegates packed the hall for an Aurum satellite session on: Scaling up shorter TB preventive treatment (TPT) - is there a role for new TB infection tests in South Africa? Prof Viol...
Fundação Aurum partners with Mozambican government to help end TB
Mozambique has shown its commitment to ending TB, with Prime Minister Carlos Agostinho do Rosário, attending the launch of the rollout of a new TB prevention therapy (TPT) recently. The Aurum Instit...
Call to action for an invigorated drive to scale up TB prevention
...
Aurum at the 53rd Union World Conference on Lung Health
The Aurum Institute will join colleagues, partners, advocates and friends at the biggest scientific conference on lung health, The Union World Conference on Lung Health which will take place virtually...
250,000 patients to benefit from free access to short-course TB prevention treatment across seven countries
Johannesburg, 24 March 2023 – The Unitaid-funded IMPAACT4TB Consortium, led by the Aurum Institute, announced today that it will provide 250,000 patient courses of short course rifapentine-based pre...
Shorter weekly course of rifapentine-isoniazid associated with much higher treatment completion rates compared to longer daily course
A randomized trial found that treatment completion was higher among HIV-positive persons who were assigned a shorter course of rifapentine-isoniazid therapy to prevent tuberculosis disease compared to...
Concern as TB Preventative Treatment Declines
...
Lancet Commission Calls for Renewed Global Response on TB
As the United Nations High-Level Meeting (UNHLM) on TB approaches, a new report from the Lancet Commission on tuberculosis releases recommendations, providing a path forward to turn the tide on this p...
The Aurum Institute at the 52nd Union World Conference on Lung Health
Aurum has extensive experience in TB research, specifically TB treatment clinical trials, TB prevention trials with vaccines, preventive therapy, epidemiological studies, implementation research an...
Invest more into combating TB, says Aurum Institute
...
Aurum at Union Conference 2023
We are excited to announce our participation in this year's Union World Conference on Lung Health, which will take place in person from November 15th to 18th at the Palais des Congrès in Paris.The Co...
Opt4TPT South Africa study team recruits and enrols participants
On 16 September 2021, the Opt4TPT study team in South Africa implemented by The Aurum Institute, started enrolling patients visiting the Chiawelo Community Health Centre (CHC) for antiretroviral the...
Enter Part of Title
Display #
5
10
15
20
25
30
50
100
All
Page 2 of 4
Start
1
2
3
4
End
Popular Tags
AurumNews
343
Tuberculosis
175
International
130
Public Health
125
HIV
95
Clinical Research
90
Implementation Research
79
Impaact4tb
63
COVID-19
60
Aurum Ghana
56
Unitaid
43
Aurum Mozambique
29
Most Read
Aurum staff appointed to Vanderbilt University
Aurum delivers life-saving medication to homes
Dablapmeds: A convenient shortcut to medication collection
World Pharmacy Month: Aurum celebrates its pharmacists
Recent Posts
Operation Phuthuma Team Showcases South African Innovations at IHI-BMJ International Forum
Youth Voices: Aurum’s Young Researchers Reflect on Groundbreaking HIV Prevention Approval
Youth Day 2025: Five Years of Action, Led by the Youth for the Youth
Request for Proposals: Supply of Itraconazole Tablets/Capsules for Histoplasmosis Treatment
Home
About Us
About Us
Who We Are
Our History
Global Footprint
Careers
Our Partners
Contact Us
Governance
President Emeritus
Board of Directors
Group Executive Management
South Africa Executive Management
Group Technical Leads
What We Do
What We Do
Clinical Research
Implementation Research
Health Programmes
Aurum Global
Global Projects
Aurum Institute Ghana
Fundação Aurum
Aurum USA
Expertise
Tuberculosis
HIV
Health Systems
Market Access
COVID-19
Antimicrobial resistance (AMR)
Accelerate 1
Affiliates
IMPAACT4TB
INNOVA
Youth Health Africa
GHI
Library
Resources
Publications
Annual Reports
Annual Financials
News & Updates
News
Latest News
Press Releases
Aurum in the News
Multimedia
Image Gallery
Multimedia